or
forgot password

    • cancer clinical trials in harvey, IL

    • Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
    Ingalls Cancer Care Center at Ingalls Memorial Hospital
    Harvey, Illinois 60426
    Lung Cancer
    Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
    Ingalls Cancer Care Center at Ingalls Memorial Hospital
    Harvey, Illinois 60426
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter
    Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
    Ingalls Cancer Care Center at Ingalls Memorial Hospital
    Harvey, Illinois 60426
    Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis
    Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer
    Ingalls Cancer Care Center at Ingalls Memorial Hospital
    Harvey, Illinois 60426
    Breast Cancer
    STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
    Ingalls Hospital
    Harvey, Illinois 60426
    Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-Small Cell Lung Cancer
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    Ingalls Cancer Care Center at Ingalls Memorial Hospital
    Harvey, Illinois 60426
    Breast Cancer
    Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer
    Ingalls Memorial Hospital
    Harvey, Illinois 60426
    Recurrent Squamous Cell Carcinoma of the Head and Neck, Carcinoma, Squamous Cell, Neoplasms, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Head and Neck Cancer
    CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
    Ingalls Memorial Hospital
    Harvey, Illinois 60426
    B-cell Chronic Lymphocytic Leukemia, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Malignant Neoplasm, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Splenic Marginal Zone Lymphoma, Waldenström Macroglobulinemia
    Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain
    Ingalls Cancer Care Center at Ingalls Memorial Hospital
    Harvey, Illinois 60426
    Kidney Cancer, Metastatic Cancer
    BIBW 2992 (Afatinib) in Head & Neck Cancer
    1200.28.0011 Boehringer Ingelheim Investigational Site
    Harvey, Illinois
    Head and Neck Neoplasms, Carcinoma, Squamous Cell
    Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer
    Ingalls Memorial Hospital
    Harvey, Illinois 60426
    Prostate Cancer
    Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
    Site Reference ID/Investigator# 8100
    Harvey, Illinois 60426
    Non-Small Cell Lung Cancer (NSCLC)
    Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer
    Site Reference ID/Investigator# 6920
    Harvey, Illinois 60426
    Metastatic Breast Cancer
    Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer
    Ingalls Cancer Care Center at Ingalls Memorial Hospital
    Harvey, Illinois 60426
    Head and Neck Cancer
    Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
    Ingalls Cancer Research Center
    Harvey, Illinois 60426
    Fatigue, Chemotherapy Side Effects
    Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.
    Ingalls Cancer Research Center
    Harvey, Illinois 60426
    Unspecified Adult Solid Tumor, Protocol Specific, Cancer
    Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer
    Ingalls Cancer Care Center at Ingalls Memorial Hospital
    Harvey, Illinois 60426
    Head and Neck Cancer
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer
    Ingalls Memorial Hospital
    Harvey, Illinois 60426
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer
    Ingalls Memorial Hospital
    Harvey, Illinois 60426
    Locally Recurrent or Metastatic Breast Cancer